---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-016920"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T01:54:53.435638+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# QHSLab Q1 2023 revenue $352,799, up 32% sequentially; gross margin 53.1%

## Summary
- Net operating loss narrowed 17.1% to $120,758 from $145,701 in Q4 2022.
- Digital Medicine ISP service revenue surged 324% sequentially to $34,467.
- Allergy segment revenue increased 20% sequentially to $49,537.
- Management expects Digital Medicine ISP revenue to grow ~100% in Q2 2023.
- Gross margin target of +500 bps expansion for fiscal 2023.

## SEC filing metadata
- accession: 0001493152-23-016920
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315223016920/0001493152-23-016920-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315223016920/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-016920
- JSON: https://secwatch.observer/filing/0001493152-23-016920.json
- Plain text: https://secwatch.observer/filing/0001493152-23-016920.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.